The stock soared 23.16% in the past three sessions, driven by strong Q2FY25 results announced on Tuesday (29 October 2024).
On a consolidated basis, net profit of Poly Medicure rose 40.62% to Rs 87.45 crore on 24.53% increase in net sales to Rs 420.02 crore in Q2 September 2024 over Q2 September 2023.
Profit before tax stood at Rs 117.98 crore in the Q1 FY25, up 45.7% YoY and up 19.83% QoQ. Operating profit margin (OPM) expanded to 27% in Q2 FY25, up from 25% in the same period last year.
Poly Medicure manufactures disposable medical items, such as IV cannula, blood bags, blood collection tubes, and infusion and transfusion sets.
